Erythrose Inhibits the Progression to Invasiveness and Reverts Drug Resistance of Cancer Stem Cells of Glioblastoma

Investigators evaluated the effect of the tetrose saccharide, erythrose, a neuroleukin inhibitor of invasiveness and drug sensitization in glioblastoma stem cells.